Flu antivirals prescribable at NHS expense

GPs can now prescribe antiviral medicines for the prophylaxis and treatment of influenza at NHS expense, in accordance with NICE guidance and the NHS Selected List Scheme (SLS).

Vaccines for the 2012/2013 season contain A/California/7/2009 as the H1N1-like virus strain, with A/Victoria/361/2011 as the H3N2-like component and B/Wisconsin/1/2010 as the influenza B component.
Vaccines for the 2012/2013 season contain A/California/7/2009 as the H1N1-like virus strain, with A/Victoria/361/2011 as the H3N2-like component and B/Wisconsin/1/2010 as the influenza B component.

The Department of Health decision was based on Health Protection Agency surveillance data showing an increase in flu activity.

Further information regarding at-risk groups and patients who are eligible for treatment at NHS expense with either Tamiflu (oseltamivir) or Relenza (zanamivir) can be found in Part XVIIIB of the Drug Tarrif.

GPs will be required to endorse prescriptions for the two influenza drugs with ‘SLS’.

Viroflu now available

In addition, the flu vaccine Viroflu (Janssen-Cilag) is now available for the current flu season.

View Viroflu drug record

View Tamiflu drug record

View Relenza drug record

Further information: Green Book – Chapter 19: Influenza

NICE guidance on the use of antiviral medicines for treatment of influenza.

NICE guidance on the use of antiviral medicines for prophylaxis of influenza.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...